Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion

被引:0
作者
K Gündüz
S J Bakri
机构
[1] Mayo Clinic,Department of Ophthalmology
来源
Eye | 2008年 / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1168 / 1171
页数:3
相关论文
共 62 条
  • [1] Rosenfeld PJ(2005)Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmic Surg Lasers Imaging 36 331-335
  • [2] Mosfeghi AA(2006)Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363-372
  • [3] Puliafito CA(2006)Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy Ophthalmology 113 1695-1705
  • [4] Avery RL(2006)Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion. A short term study Retina 26 279-284
  • [5] Pieramici D(2006)Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema Retina 26 356-357
  • [6] Rabena M(1984)Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 271-282
  • [7] Castellarin AA(2007)Pharmacokinetics of intravitreal bevacizumab (Avastin) Ophthalmology 114 855-859
  • [8] Nasir MA(2003)Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 681-686
  • [9] Giust MJ(2007)Pharmacokinetics of intravitreal ranibizumab (Lucentis) Ophthalmology 114 2179-2182
  • [10] Avery RL(2005)Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion Retina 25 851-858